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Background. Carcinosarcoma is an extremely rare malignant neoplasm, with both a malignant epithelial and mesenchymal
component, that rarely affects the larynx. Aim. Aim of this paper is to describe the case of a patient affected by a larynx
carcinosarcoma treated by endoscopic horizontal partial laryngectomy with CO(2) laser and particularly discuss the histogenetic
hypothesis as well as the possible treatmentmodalities of this rare lesion.Methods.Case report and literature review.Discussion and
Conclusion. Still little is known about the biology of carcinosarcoma and there is still no consensus in the literature on the treatment
of these tumors. Endoscopic horizontal partial laryngectomy could represent another treatment option in selected cases.
1. Introduction
Carcinosarcoma is a malignant tumor with both a malignant
epithelial andmesenchymal component. Most reported cases
occurred in the major salivary glands; other reported sites
are larynx and pharynx and, less frequently, oral and nasal
cavities and esophagus [1–5].
Carcinosarcoma of larynx and hypopharynx represents
less than 1% of all malignant tumours [6]. Reported risk
factors are those of squamous cell carcinoma (i.e., smoking
and alcoholism), as well as exposure to radiation. The classic
clinical presentation features of the larynx carcinosarcoma
are dysphonia and eventually dyspnea due to laryngeal
obstruction [7].
The histogenesis of carcinosarcoma is controversial: its
origin has been ascribed to the differentiation of primi-
tive blastic mesenchymal cells. At diagnosis, a true carci-
nosarcoma exhibits a malignant mesenchymal component
(sarcoma), as well as an epithelial component (carcinoma
or adenocarcinoma). The histologic exam often reveals the
presence of pleomorphic cells and atypical mitosis.
Most of the cases of laryngeal carcinosarcoma have
been treated with laryngectomy. Only in few cases organ
preservation has been achieved by partial laryngectomy with
external cervical approach [8, 9].
In this paper we describe a case of larynx carcinosarcoma
treated by endoscopic laser CO(2) horizontal partial laryn-
gectomy.
2. Case Report
A 61-year-old woman complaining from dysphagia for 6
months as well as dysphonia and dyspnoea for 2 months was
referred to the ENTDepartment at the University Hospital of
Ferrara in April 2012.The patient also reported weight loss of
about 5-6 pounds in the last months before. She had a history
of smoking, hypertension, diabetes, hypercholesterolemia,
vascular encephalopathy, and multiple vascular diseases. In
particular, she underwent bilateral carotid arteries throm-
boendarterectomy. She also had vascular surgery for aortic
dissection in the previous years; the last CT angiographies
also showed a dissection of the left common carotid artery
(with severe lumen reduction) and several calcified athero-
matic lesions of thoracic and abdominal aorta.
The ENT evaluation disclosed the presence of an epiglot-
tic laryngeal face neoformation. No lymph nodes were
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Figure 1: Definitive histological examination showing a carcinosarcoma with carcinomatous and sarcomatous components. Immunohis-
tochemistry with monoclonal antibodies (anticytokeratin CK7, CK 8–18, and CK 5-6) for actin, P63, vimentin, S100, desmin, and EMA
(epithelial membrane antigen) has been performed.The tumour showed strong positivity for vimentin, EMA, and focal elements for CK 8–18.
(a) Hematoxylin-eosin (20x). “In situ” squamous cell carcinoma with cells infiltrating the subepithelial corium. Lower right: undifferentiated
spindle cell carcinoma cells. (b) Hematoxylin-eosin (20x). “In situ” squamous cell carcinoma with atypical cells at the basal layers, a
sarcomatous component, and hemosiderin deposits. (c) EMA (20x). Immunohistochemistry: carcinomatous cells with membrane positivity
for EMA. (d) CK 8–18 (40x): focal positivity for cytokeratin 8–18.
detectable clinically at the neck inspection. The remaining
head and neck exam was unremarkable.
The patient underwent head, neck, and chest contrast
CT scans that disclosed the presence of a lesion, with inho-
mogeneous contrast enhancement of a transverse diameter
of 25 × 17mm and a craniocaudal extension of 22mm, in
correspondence to the laryngeal side of the epiglottis. The
scan also showed a left submandibular lymph node of 10 ×
14mm, as well as some bilateral jugular and subcentrimetic
digastric lymph nodes with reactive features. Nonetheless,
the fine needle aspiration cytology (ultrasound-guided) of
the lymph nodes revealed lymphocytes at different stages of
maturation and no neoplastic cells.
A biopsy under local anaesthesia was then performed.
Since the histological examination disclosed the malignant
nature of the lesion, and considering the important comor-
bidities of the patient, she was evaluated by a multidisci-
plinary team (composed of the ENT surgeon, the vascular
surgeon, the anaesthesiologist, the oncologist, and the radia-
tion therapy oncologist), in order to establish the best possible
treatment. It was therefore decided to perform a microlaryn-
goscopy in order to evaluate the possibility of an endoscopic
surgical excision of the laryngeal tumour, while at the same
time it was established not to proceed with the lymph node
prophylactic dissection in the same surgical session due to
(i) the complex and severely compromised situation of the
neck vasculature; (ii) the absence of clinical, radiological, and
cytological evidence of lymph node involvement.
Under general anaesthesia and after tracheotomy, a
microlaryngoscopy was then performed; since it confirmed
the possibility of an endoscopic excision, an endoscopic
CO(2) laser horizontal partial laryngectomy was performed.
During anaesthesia the patient also underwent an
esophageal-gastro-duodenoscopywithout evidence of lesions
in all the examined districts.
The definitive histological examination disclosed a carci-
nosarcoma of the entire epiglottis laryngeal side (including
the petiole) (Figure 1) with disease-free margins (pT2N0M0,
Stage II).
The postoperative course was uneventful. At 3 weeks after
surgery the patient was evaluated by the multidisciplinary
team and considering the histological definitive diagnosis no
indications for further treatments were proposed.
A tracheoplasty was performed after 3 weeks as laryn-
goscopy revealed regular surgical outcomes with conserved
glottic space.
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At the moment the patient is followed up regularly, she
is disease-free at 12 months after surgery, and she is showing
good functional results and a good quality of life.
3. Discussion and Conclusion
Carcinosarcoma is a rare malignant tumour with both car-
cinomatous and sarcomatous components. It is difficult to
assess the true incidence of this pathological entity, even
if it has been estimated that carcinosarcoma of larynx
and hypopharynx represents less than 1% of all malignant
tumours [6], and both sexes are equally affected.
About its histogenesis, some hypotheses have been pro-
posed as carcinosarcoma could be considered as (1) a carci-
noma with a reactive mesenchymal component; (2) a tumour
in which carcinoma and sarcoma develop simultaneously
and independently; (3) a tumour arising from embryonic
epithelial andmesenchymal residual tissues; (4) amalignancy
arising from a totipotent malignant cell that therefore dif-
ferentiates into carcinomatous and sarcomatous components
[10–12].
According to the World Health Organization (WHO)
classification [12], three different subtypes of malignant
mixed tumours can be identified: carcinoma ex-pleomorphic
adenoma, metastasizing mixed tumor, and carcinosarcoma
[13, 14]. In carcinoma ex-pleomorphic adenoma, the epithe-
lial component only becomes malignant (thus developing
an adenocarcinoma), while in metastasizing mixed tumor
and carcinosarcoma, or true malignant mixed tumor, there is
a dual malignant component (carcinomatous and sarcoma-
tous) which are therefore considered biphasic [15, 16].
Concerning the localization of carcinosarcomas, major
salivary glands are the most frequent sites reported in head
and neck, whereas other sites such as nasal and oral cavity,
nasopharynx, bronchus, lung, and trachea are rare, and
larynx is considered even more rare [1–5, 17]. The clinical
presentation of laryngeal carcinosarcoma is similar to that of
other laryngeal carcinomas [18], with dysphonia, dyspnoea,
and dysphagia as the most frequent symptoms reported.
There is no consensus about the best treatment options
for carcinosarcoma; however surgical excision with wide
margins is the most recommended treatment [17, 18]. The
specific therapeutical approach should be anyway tailored to
the tumor stage, localization, and size.
In the case presented a supraglottic horizontal laryngec-
tomy was performed endoscopically with laser CO(2). It has
already been reported that the effectiveness of endoscopic
laser horizontal laryngectomy is similar to the external
approach in terms of oncological outcome (as the surgical
margins were disease-free) and functional results, in case of
supraglottic laryngeal squamous cell carcinoma [19]. How-
ever to our knowledge this is the first case of laryngeal carci-
nosarcoma that has been treated endoscopically. We decided
not to proceed with a prophylactic neck dissection, due to
(i) the general health problems of the patient, in particular
the high neck vascular impairment (that represented a strong
contraindication to a neck dissection), (ii) the laryngeal
cancer stage (T2NOMO), and (iii) the definitive histologic
diagnosis.
However, the patient is under strict clinical (endoscopic)
and radiologic (echographic and/or CT-PET) followup and
presently is without evidence of disease.
On radiotherapy there is no consensus in the literature
as the mesenchymal component is reported to be resistant to
irradiation [12].
The prognosis of carcinosarcoma is also controversial
[12], and it is reported to be worse than that of squamous
cell laryngeal carcinoma [12]. Nonetheless, due to the extraor-
dinarily rare incidence of this tumor, it will be essential to
acquire more information on its biological behaviour, so that
appropriate treatment modalities can be defined.
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